Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion.
about
Prediction of co-receptor usage of HIV-1 from genotypeRabbit Anti-HIV-1 Monoclonal Antibodies Raised by Immunization Can Mimic the Antigen-Binding Modes of Antibodies Derived from HIV-1-Infected HumansThermodynamic Signatures of the Antigen Binding Site of mAb 447–52D Targeting the Third Variable Region of HIV-1 gp120Crystal Structure of a Soluble Cleaved HIV-1 Envelope TrimerThe evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approachMax Bergmann lecture protein epitope mimetics in the age of structural vaccinologyReliable genotypic tropism tests for the major HIV-1 subtypesAntigenic and 3D structural characterization of soluble X4 and hybrid X4-R5 HIV-1 Env trimersSensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120Fitness epistasis and constraints on adaptation in a human immunodeficiency virus type 1 protein regionAnalytical and biological considerations in the measurement of cell-associated CCR5 and CXCR4 mRNA and proteinA signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity.Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism.Insights into the structure, correlated motions, and electrostatic properties of two HIV-1 gp120 V3 loops.A small set of succinct signature patterns distinguishes Chinese and non-Chinese HIV-1 genomes.A diagnostic HIV-1 tropism system based on sequence relatedness.Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.Selection with a peptide fusion inhibitor corresponding to the first heptad repeat of HIV-1 gp41 identifies two genetic pathways conferring cross-resistance to peptide fusion inhibitors corresponding to the first and second heptad repeats (HR1 and HInduction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithmSensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors.HIV-1 tropism testing and clinical management of CCR5 antagonists: Quebec review and recommendations.The CCR5-delta32 polymorphism as a model to study host adaptation against infectious diseases and to develop new treatment strategies.Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving.Mimicking Protein-Protein Interactions through Peptide-Peptide Interactions: HIV-1 gp120 and CXCR4Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion.Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing.Analysis of the neutralization breadth of the anti-V3 antibody F425-B4e8 and re-assessment of its epitope fine specificity by scanning mutagenesis.An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.Amino acid covariation in a functionally important human immunodeficiency virus type 1 protein region is associated with population subdivision.Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?Fitness valleys constrain HIV-1's adaptation to its secondary chemokine coreceptor.Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodiesSynthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design.Search for identical octapeptides in unrelated proteins: Structural plasticity revisited.HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope.Structural dynamics of V3 loop with different electrostatics: implications on co-receptor recognition: a molecular dynamics study of HIV gp120
P2860
Q21090162-487ECC3A-E7B3-4344-9341-4EF2D416A860Q27679123-DBC267BD-97AC-4596-B354-3D4B17153947Q27679559-C0AF88BF-8689-4B4E-B185-4FA4E5F57B3AQ27680496-8964442B-1A27-46CF-9809-EF39D4797D07Q28476558-CB7D1EBF-4712-4422-BDC2-DF3C4F4FECA3Q30155145-3E20F522-E6C1-4382-8649-560EF1DDACF9Q30372085-733C9C60-82E2-4F05-90F7-7C63F7B7594AQ30580101-3E8DD4B6-6CFF-4F24-B56A-3D9552C173B7Q33622927-351E9597-244B-40D3-9006-BE954611EFB3Q33820645-71179CC4-B1B1-4839-9591-B73274E6A034Q33853183-2153CA21-9B83-4079-97D0-88E919964DDBQ33962644-8AFDEE4E-7B3E-4DC6-8366-F0BDF2DCD750Q34005516-182E7114-20F1-4AE7-940F-A8DCE629CC5CQ34482589-8F652FB1-8465-4034-8D05-8CD4F3A777A0Q34490720-298AD039-9D2A-4E36-A770-C4FDE7757266Q34634310-1AA240A7-6AAD-4439-8251-A3066F1642F5Q34983107-33242B53-43BB-4498-B9CF-25DC3CC2ED59Q35111062-A83DB37A-FE73-41CD-8F84-D92116C50BB1Q35599288-25DF547F-EDAF-4B1C-83CA-341DAF9436DCQ35955770-F5EAF96D-2EC0-4933-B02A-7F4DF049ABCDQ36690585-187C2565-4462-4587-8654-1CADAB6B4889Q36826759-5BF31ED6-B40F-42A1-A1D3-B7CAA968BBBEQ36827348-6FE17172-0A35-4DFE-94B4-8F20EBEE2E7EQ37525642-394ABF4C-31A2-46A8-BC6C-B738B5FA9537Q37895793-250F64E1-E36D-4A18-9F85-19D7997ED27FQ38014473-0451656A-1F7C-4A51-ADBC-089703750A99Q39034394-FC62C3E2-82BD-4FCF-BAEC-E47F7A57AEE9Q40127843-BC80BD12-FF22-4153-8383-B80D4261C468Q40134363-F351371E-ECF6-4F6F-AB4F-71D2F2C9849BQ40147993-42CEF969-4C98-40AE-96C7-6BC9ED84D620Q40901260-3ACC3A77-AA6B-44FF-9383-D00B4D945197Q42050186-3FC8FFDF-4F75-4348-964F-A0117C899250Q42234370-AE9E9110-C0E6-4DBE-9B3F-5B23D769E67DQ42239239-934F723B-3133-4E24-BAA2-EC444D8D6852Q42576275-4E057494-8A6A-4DD2-9141-4F1FF7F03BB9Q45361823-65CF2A31-17A2-4DAD-AB09-85A9564A9E29Q51276233-A5A88BE9-15D9-422B-8C06-FF1CAF8C5C74Q52352265-15A88A20-BECD-4876-BC3E-0EECFDC51BDBQ56790128-E418E2F5-9CF0-4071-BDA2-23B63CB10D03
P2860
Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular switch for alternati ...... ions for phenotype conversion.
@ast
Molecular switch for alternati ...... ions for phenotype conversion.
@en
type
label
Molecular switch for alternati ...... ions for phenotype conversion.
@ast
Molecular switch for alternati ...... ions for phenotype conversion.
@en
prefLabel
Molecular switch for alternati ...... ions for phenotype conversion.
@ast
Molecular switch for alternati ...... ions for phenotype conversion.
@en
P2093
P2860
P356
P1476
Molecular switch for alternati ...... ions for phenotype conversion.
@en
P2093
Jacob Anglister
Osnat Rosen
Sabine R Quadt-Akabayov
P2860
P304
13950-13955
P356
10.1073/PNAS.0606312103
P407
P577
2006-09-11T00:00:00Z